CooperCompanies announced its second quarter 2024 results with a 7% increase in revenue year-over-year, reaching $942.6 million. GAAP EPS increased by 122% to $0.44, and non-GAAP EPS increased by 10% to $0.85. The company has raised its fiscal year 2024 financial guidance.
Revenue increased 7% year-over-year to $942.6 million.
CooperVision (CVI) revenue was up 8% to $635.9 million.
CooperSurgical (CSI) revenue was up 6% to $306.7 million.
GAAP diluted earnings per share (EPS) of $0.44, up $0.24 or 122% from last year's second quarter.
The Company raised its fiscal year 2024 financial guidance.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance